Navigation Links
Top 10 Things Pharma Should Know About India - Free Paper From Decision Resources
Date:10/27/2008

Competition From Alternative Medicine and Relationships With Healthcare Facilities Are Among the Issues Detailed in the Paper

WALTHAM, Mass., Oct. 27 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, has made available for free on their Web site a paper that presents the top 10 highlights of the Indian pharmaceutical market that are integral to success. This list was compiled using data and information from Decision Resources' Emerging Markets--India Report Series.

The new paper entitled Top 10 Things Pharma Should Know About India, ranks competition from alternative medicine, which is widely used and promoted by the Indian government, as number 10 on the list. India uses various traditional (Herbal/Ayurvedic) and alternative medicinal methods besides Western medicine for patients seeking treatment of certain chronic ailments (e.g., rheumatism).

Building relationships with private and public healthcare facilities to promote a branded drug is ranked at number 9. On average, 65 percent of Indians access private hospitals, clinics and doctors and 35 percent rely on government-sponsored institutions and doctors. This pattern holds true across geographic regions; 70 percent of urban households and 63 percent of rural households use private healthcare.

EMERGING MARKETS REPORTS

The Ultimate Analysis of Pharmaceutical Markets in China and India

Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis. Each report assesses the commercial opportunity in the pharmaceutical market for a disease based on population demographics, economic development, disease epidemiology and changing physicians' practices.

About Decision Resources

Decision Resources (http://www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

Natalia Morales Elizabeth Marshall

Decision Resources Decision Resources, Inc.

781-296-2691 781-296-2563

nmorales@dresources.com emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HowToDoThings.com Brews Up New Uses for Coffee That Will Perk You Up in Recognition of Marchs Caffeine Awareness Month
2. When it comes to emotions, Eastern and Western cultures see things very differently: Study
3. Ten Things You Can Do to Reduce Your Cancer Risk
4. The Best Things in Life Are ... In Better Health & Living(R), A Free, Premium Magazine Launching April 26 in the Twin Cities
5. Cancer was one of the best things to happen to me... but I worry about the future
6. Cancer was one of the best things to happen to me ... but I worry about the future
7. The Shape of Things to Come: Website Gives the Lowdown on Liposuction, Pioneers the Field by Offering Consumers $800 Coupons Toward Procedures
8. Surviving Your PreRetirement Years: 15 Things You Must Do Between 50 and 64
9. The Most Ordinary Things Can Cause the Most Extraordinary Eye Injuries, Says the Oklahoma Academy of Ophthalmology
10. The Most Ordinary Things Can Cause the Most Extraordinary Eye Injuries, Says Texas Ophthalmological Association
11. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce that ... Mr. Still was selected through a careful months-long search by the RBMA Board of ... our members, has been a part of building the RBMA since 1992,” said RBMA ...
(Date:3/28/2017)... ... ... With less than 10,000 dermatologists in the United States and more than ... the desire to conquer breakouts and eliminate skincare stress is widespread. Curology , ... released its inaugural survey on the State of Acne in America. , The ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency ... in early March. , The seed processing plant opened in Marshallville in 2006, and ... The new office allows opportunity for transition of Patten Seed operations to the Middle ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... “A Prophets Bones”: a thrilling adventure that ... Donald Quinn. , “There were things that his parents and teachers had asked of him ... way that he was going to defy the Almighty Creator. There were some who would ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... New York , March 28, 2017 ... a largely consolidated vendor landscape, with the top three ... Agilent Technologies accounting for a significant 49% of the ... a recent report. The vendor landscape is intensely competitive ... share in the overall market. These factors have restricted ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, ... in Israel . This new business entity, Emosis ... mostly dedicated to research and development of novel assays complementing the ... also, when relevant, locally support commercialization and sales development of Emosis ... This strategic ...
(Date:3/28/2017)... 2017  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a ... and other unmet medical needs, announced today two ... Research annual meeting.  The first poster to be ... of ENMD-2076 in Combination with Anti-PD1 in Syngeneic ... be presented on April 4 is entitled " ...
Breaking Medicine Technology: